tacrine has been researched along with Cholangiocarcinoma in 1 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Cholangiocarcinoma: A malignant tumor arising from the epithelium of the BILE DUCTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Q | 1 |
| Lin, M | 1 |
| Feng, X | 1 |
| Ma, F | 1 |
| Zhu, Y | 1 |
| Liu, X | 1 |
| Qu, C | 1 |
| Sui, H | 1 |
| Sun, B | 1 |
| Zhu, A | 1 |
| Zhang, H | 1 |
| Huang, H | 1 |
| Gao, Z | 1 |
| Zhao, Y | 1 |
| Sun, J | 1 |
| Bai, Y | 1 |
| Jin, J | 1 |
| Hong, X | 1 |
| Zou, C | 1 |
| Zhang, Z | 1 |
1 other study available for tacrine and Cholangiocarcinoma
| Article | Year |
|---|---|
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism.
Topics: Amino Acid Substitution; Bile Duct Neoplasms; Cell Line, Tumor; Cellular Reprogramming; Cholangiocar | 2020 |